Previous 10 | Next 10 |
2024-03-13 08:29:15 ET Read the full article on Seeking Alpha For further details see: KB Financial, BeiGene, Legend Biotech among premarket gainers' pack
2024-03-11 12:09:08 ET Legend Biotech Corporation (LEGN) Q4 2023 Earnings Conference March 11, 2024 08:00 AM ET Company Participants Jessie Yeung - Head of Investor Relations and Public Relations Ying Huang - Chief Executive Officer Lori Macomber - Chief Financia...
2024-03-11 07:01:47 ET More on Legend Biotech Legend Biotech: Solid Traction With Carvykti Rollout Legend Biotech FY 2023 Earnings Preview Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy Seeking Alpha’s Quant Rati...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $159 million and $500 million for the fourth quarter and full year 2023, respectively CHMP recommended CARVYKTI ® label expansion in earlier lines of treatment for adult patients with rela...
2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
2024-03-08 13:50:25 ET More on Legend Biotech Legend Biotech: Solid Traction With Carvykti Rollout Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy ...
2024-03-08 09:50:03 ET Major earnings expected before the bell on Monday include: Ballard Power Systems ( BLDP ) Eltek ( ELTK ) Endeavour Silver ( EXK ) Legend Biotech ( LEGN ) NewLake Capital Partners ( OTCQX:NLCP ) Overseas Shipholding Group (...
2024-03-07 10:30:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for LEGN on March 7, 2024 10:00AM ET. The previous analyst recommendation was Underperform. LEGN was trading at $63.385 at issue of the analyst recommendation. The overall analyst consensus : B...
2024-02-25 05:00:00 ET Summary AlphaGen Therapeutics and ArtBio, two targeted RLT companies, forged a far-reaching agreement to expand ArtBio’s market and develop new RLTs. Biocytogen Pharma signed an antibody evaluation/option agreement with Gilead Sciences, granting acces...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...
VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before. While researchers continue to search for a reason why this is happening, s...
2024-06-17 07:00:07 ET Asthika Goonewardene from Truist Financial issued a price target of $88.00 for LEGN on 2024-06-17 06:19:00. The adjusted price target was set to $88.00. At the time of the announcement, LEGN was trading at $42.45. The overall price target consensus...